Rifampin: effect of two-day treatment on the meningococcal carrier state and the relationship to the levels of drug in sera and saliva.
D002353:Carrier State / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D008589:Meningococcal Infections / Q000188:drug therapy*; D009305:Nasopharynx; D012293:Rifampin / Q000008:administration & dosage / Q000032:analysis / Q000097:blood* / Q000627:therapeutic use*; D012463:Saliva / Q000032:analysis*
D012293:Rifampin